SMADS ARE THE CENTRAL-COMPONENT IN TRANSFORMING-GROWTH-FACTOR-BETA SIGNALING

Citation
Rw. Padgett et al., SMADS ARE THE CENTRAL-COMPONENT IN TRANSFORMING-GROWTH-FACTOR-BETA SIGNALING, Pharmacology & therapeutics, 78(1), 1998, pp. 47-52
Citations number
38
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
01637258
Volume
78
Issue
1
Year of publication
1998
Pages
47 - 52
Database
ISI
SICI code
0163-7258(1998)78:1<47:SATCIT>2.0.ZU;2-4
Abstract
Until recently, little was known about how transforming growth factor (TGF)-beta signals are transduced to the nucleus. With the discovery o f the Smad proteins initially in Drosophila and C. elegans, the unrave ling of the pathway has begun. Nine different vertebrate members also have been reported, indicating that Smads are a conserved component of the TGF-beta pathway. Currently, there are three functional classes o f Smads. Class I Smads are phosphorylated by TGF-beta receptors and mo ve to the nucleus. The Class II Smads function with Class I Smads, whi le Class III Smads antagonize the function of Class I Smads. New evide nce shows that Smads bind specific DNA sequences and induce transcript ion of downstream target genes, thus placing the Smads at the center o f the TGF-beta signaling pathway. (C) 1998 Elsevier Science Inc.